返回
J
Julien Edeline
centre eugene marquis
52H指数
394论文数
1.8W被引数
收录论文 150
发表时间
A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY Data一项多中心国家II期临床试验,评估Tislelizumab单药治疗Child-Pugh B级和ALBI 1级或2级肝功能评分的肝细胞癌患者的疗效:UCGI 41 HESTIA试验设计与初步安全性数据

